Notes
Slide Show
Outline
1
MALIGNANT SALIVARY GLAND TUMORS
  • Mucoepidermoid carcinoma
  • Adenoid cystic carcinoma
  • Acinic cell carcinoma
2
Mucoepidermoid Carcinoma
  • Malignant salivary gland tumor is of varying degree of aggressiveness composed of mucous secreting and stratified squamous epithelial cells and lacking a capsule.
3
Mucoepidermoid Carcinoma
  • CLINICAL FEATURES:
  • Adulthood tumor
  • Significant female predilection
  • SITE:
  • 50% MEC occur in the parotid gland (arising in superficial lobe)
  • 20% occur on the palate
  • Rest of the lesions arising from the minor salivary glands with the buccal mucosa, lips, tongue and retro molar areas to be the favored sites.
  •                                                                           C/F.. Cont..d
4
Mucoepidermoid Carcinoma
  • The tumor may be movable, which is an uncommon feature for a malignant tumor. High grade lesions are often fixed to the adjacent tissues.
  • Their size is 1-4 cm when diagnosed.
  • There may be facial weakness due to VII nerve involvement.
5
Mucoepidermoid Carcinoma
6
Mucoepidermoid Carcinoma
  • HISTOPATHOLOGY:
  • They have three dominant cell types
  • Mucinous, epidermoid and intermediate
  • Their cells are arranged in the nests and diffuse sheets that may surround cystic spaces
  • There is no capsule, but the edge of the tumor is well-demarcated


7
Mucoepidermoid Carcinoma
  • There may be focal areas of malignant cells infiltrated into the normal salivary tissue
  • Tumors predominant mucous cells and more cystic spaces are classified as low grade (with limited metastatic potential)
  • Those with solid sheets and fewer mucous secreting cells and high proportion of stratified squamous epithelium are classified as high grade tumors
8
Mucoepidermoid Carcinoma
9
Mucoepidermoid Carcinoma
 LOW GRADE              /            HIGH GRADE
10
Mucoepidermoid Carcinoma
  • TREATMENT/PROGNOSIS:
  • Low grade tumors follow a benign course whereas high grade show distant metastasis to the regional lymph nodes as well ( cervical lymph nodes)
  • Treatment of primary malignancy is managed with surgery followed by radiotherapy to the primary site.
  • Prognosis depends on the histological grade of the malignancy.
11
ADENOID CYSTIC CARCINOMA
12
ADENOID CYSTIC CARCINOMA
  • It is a malignant salivary gland tumor composed of cuboidal cells in a solid cribriform tubular pattern
  • ACC is one of the most deceptive and frustrating tumor of the head and neck region
  • ORIGION:
  • ACC arises from intercalated duct reserve cells or the terminal tube complex
13
ADENOID CYSTIC CARCINOMA
  • CLINICAL FEATURES:
  • Peak incidence is in sixth decade of life with slight female predilection
  • 50-70% cases reported are in the minor salivary glands, the major glands that are affected are the parotid glands
  • In major salivary glands, the clinical appearance is that of a unilocular mass, which is firm on palpation
  • There might be some pain and tenderness
14
ADENOID CYSTIC CARCINOMA
  • The lesion has a slow growth rate.
  • Facial nerve paralysis or weakness maybe the initial symptom
  • Bone invasion occurs frequently.  There are no radiographic changes initially as there is infiltration through the marrow spaces
  • Metastasis is often seen in lungs
  • The tumor has tendency to invade the perinural spaces


15
ADENOID CYSTIC CARCINOMA
  • HISTOPATHOLOGY:
  • Slight microscopy will reveal cribriform or cylindro-matous pattern (Swiss cheese pattern)
  • Areas of necrosis with solid clusters of cells indicate more aggressive form of the disease
  • The individual tumor cells are cuboidal small with a disproportionate large nuclei
16
ADENOID CYSTIC CARCINOMA
  • There are no mitotic figures
  • There is formation of pseudocystic spaces that contain variety of acellular substances
  • Myoepithelial cells may represent a minor part of the cellular component
17
ADENOID CYSTIC CARCINOMA
18
ADENOID CYSTIC CARCINOMA
19
ADENOID CYSTIC CARCINOMA
20
ADENOID CYSTIC CARCINOMA
21
ADENOID CYSTIC CARCINOMA
  • TREATMENT/PROGNOSIS:
  • Primary lesion always requires surgical innervation in the parotid gland with resection in the form of superficial parotidectomy or deep lobulectomy
  • Post surgical radiotherapy has shown promising results
  • Multiple agent chemotherapy has shown some promise in the management of the patients with metastatic disease
  • 5 years survival rate is approximately 70%
  • After 15 years, the rate drops to 10% only.